Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesDermatologyBaylor Scott & White Health Plan laser coverage | …
    Ask Trek AI about this page
    CurrentBaylor Scott & White Health PlanPolicy 099

    Laser Treatment of Skin Lesions

    Customize your policy alerts

    Sign up for Baylor Scott & White Health Plan Policy 099 alerts

    Get alerted when Policy 099 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, prior authorization, and coverage criteria for laser therapy for various skin lesions for Baylor Scott & White Health Plan members; applies across lines of business and references Medicare and Texas Medicaid guidance where applicable.

    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyLaser Treatment of Skin Lesions
    Policy CodePolicy 099
    Change TypeRoutine review — no material changes
    Effective Date05/01/2026
    Last ReviewApr 23, 2026
    Next Review Date04/23/2027
    Key ActionObtain prior authorization before performing laser treatment for skin lesions.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Prior Auth Requiredauthorization requirement
    099policy id

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    05/01/2026effective
    NC?applies to

    Coverage Criteria

    Conditions considered medically necessary

    BSWHP may consider laser therapy medically necessary for ONE or more of the following conditions:

    Keloids/hypertrophic scars: Keloids or other hypertrophic scars which are secondary to an injury or covered surgical procedure AND one or more of the following: causes significant pain requiring chronic analgesic medication OR results in significant functional impairment.
    Plaque psoriasis: Mild to moderate localized plaque psoriasis when ALL of the following criteria are met: affects 10% or less of body area AND have failed to adequately respond to 3 or more months of topical treatments.10% body area; >=3 months topical therapy
    Port wine birthmark (stain): on the face and/or neck in members <= 18 years of age; on the face and/or neck in members > 18 years of age when symptomatic (bleeding, infection, pain, ulceration) or produces functional impairment; on the trunk or extremities when symptomatic (bleeding, infection, pain, ulceration) or produces functional impairment.age <=18 applies to face/neck; symptomatic or functional impairment criteria apply regardless of location
    Infantile hemangiomas (IH): Infantile hemangiomas in children when decisions are made in consultation with a hemangioma specialist AND one or more of the following: life-threatening complication (e.g., airway obstruction, liver IH with high-output congestive heart failure and severe hypothyroidism) OR functional impairment (e.g., periocular IH >= 1 cm; IH involving the nose, lip, or oral cavity) OR ulceration of any size involving lips, columella, superior helix of ear, gluteal cleft and/or perineum, perianal skin, or other intertriginous areas OR structural anomalies (segmental IH of face, scalp, lumbosacral or perineal area) OR potential for permanent disfigurement (facial IH of nasal tip or lip of any size; any facial location >2 cm or >1 cm if <=3 months of age; scalp IH >2 cm).periocular >=1 cm; facial IH >2 cm (or >1 cm if <=3 months of age); scalp IH >2 cm

    Consultation with a hemangioma specialist is required

    Cosmetic (Not covered)

    Laser therapy is considered cosmetic for the following conditions (list is NOT inclusive):

    Cosmetic indications: Dyschromia; removal of hair for pseudofolliculitis barbae or follicular cysts; removal of spider angiomata; removal of telangiectasias in adults; rosacea; acne; granuloma faciale; rhinophyma; genital warts; superficial glomangiomas; pyogenic/pyrogenic granuloma; verrucae.

    Cosmetic treatments are generally not a benefit for many plans.

    Experimental / Investigational

    Pulsed Dye Laser therapy is considered experimental and investigational for all other indications.

    Many skin lesions are considered cosmetic and, as such, treatment with laser therapy is often not a benefit under many plans. The policy lists common cosmetic indications (not inclusive) that are excluded from coverage; providers should verify plan-specific benefit language in the member’s Evidence of Coverage or Summary Plan Description before requesting services.

    Laser therapy for the conditions listed as cosmetic in this policy is considered not medically necessary and is generally not covered. Examples of such cosmetic indications include dyschromia, hair removal for pseudofolliculitis barbae, spider angiomata, telangiectasias in adults, rosacea, acne, granuloma faciale, rhinophyma, genital warts, superficial glomangiomas, pyogenic granuloma, and verrucae; this list is not exhaustive.

    Coding

    CPT CodesCPT
    17106Destruction of cutaneous vascular proliferative lesions (e.g., laser technique); less than 10 sq cm
    17107Destruction of cutaneous vascular proliferative lesions (e.g., laser technique); 10.0 to 50.0 sq cm
    17108Destruction of cutaneous vascular proliferative lesions (e.g., laser technique); over 50.0 sq cm
    ICD-10 Codes (examples)ICD-10
    D18.00 - D18.09Hemangioma
    L40.0Psoriasis vulgaris (plaque psoriasis)
    L91.0Hypertrophic scar (keloid)
    Q82.5Congenital non-neoplastic nevus (Port wine stain)

    Provider Actions & Requirements

    Prior Authorization

    Prior authorization required

    Prior authorization is required for laser treatment of skin lesions; review the member's plan EOC/SPD for coverage details and applicable Medicare/Medicaid guidance before proceeding.

    • Policy header: PRIOR AUTHORIZATION: Required
    • Recommendation to review plan EOC/SPD and applicable NCD/LCD or Medicaid TMPPM guidance
    Step Therapy

    Topical therapy failure required prior to laser

    For mild to moderate localized plaque psoriasis, laser therapy is covered only when the condition affects 10% or less of body area AND the member has failed to adequately respond to 3 or more months of topical treatments.

    • Must have failed ≥3 months of topical treatments before laser is considered
    • Applies when disease affects ≤10% of body surface area

    Background

    Lasers produce high-intensity light generated within a medium (gas, liquid/dye, or solid) that determines the device’s specific wavelength. Clinical effects depend on the device’s wavelength, pulse duration, and the target tissue’s light absorption characteristics; these parameters determine whether the laser will cut, coagulate, seal, or otherwise alter tissue. Because different media produce different wavelengths (visible or infrared), device selection must match the clinical target and desired tissue response.

    Definitions

    Laser — definition and device characteristics
    DefinitionLaser: light amplification by stimulated emission of radiation (acronym).
    Energy source / mediaLaser media may be gas (eg, argon, krypton, carbon dioxide), liquid/dye, or solid (eg, ruby, neodymium:YAG, alexandrite).
    Wavelength relevanceEach medium produces a specific wavelength (visible or infrared) that determines clinical applications.
    Mechanism of tissue effectLasers concentrate light to produce cutting, burning, or sealing of tissue via wavelength, pulse duration, and tissue absorption characteristics.
    Key device characteristicsImportant device parameters: medium, wavelength peak, pulse duration, and target tissue absorption. These determine indication and effect.
    Policy Summary
    PayerBaylor Scott & White Health Plan
    PolicyLaser Treatment of Skin Lesions
    Policy CodePolicy 099
    Change TypeRoutine review — no material changes
    Effective Date05/01/2026
    Last ReviewApr 23, 2026
    Next Review Date04/23/2027
    Key ActionObtain prior authorization before performing laser treatment for skin lesions.
    SourceLink
    On This Page
    Coverage CriteriaCodingProvider Actions & RequirementsBackgroundDefinitions
    Documentation Required

    Coding and documentation note

    Document the CPT procedure code(s) and applicable ICD-10 diagnosis code(s) and confirm the member meets the policy's clinical criteria; inclusion of a code in the policy does not guarantee reimbursement.

    • Example CPT codes: 17106, 17107, 17108
    • Example ICD-10 codes: D18.00–D18.09, L40.0, L91.0, Q82.5
    Denial Risk

    Denial risk if prior authorization not obtained

    Failure to obtain prior authorization when required may result in denial of service.